BioLineRx, Hemispherian to Present GLIX1 Glioblastoma Data at EANO 2026
Image
Tel Aviv and Oslo – September 15, 2026 -- BioLineRx Ltd. (NASDAQ/TASE: BLRX) and Hemispherian AS will present two abstracts on their oncology candidate GLIX1 at the 21st Meeting of the European Association of Neuro-Oncology (EANO 2026) in Rome, Italy, September 24-27, with one abstract selected for oral presentation.